Literature DB >> 14970829

Prepulse inhibition and habituation of acoustic startle response in male MDMA ('ecstasy') users, cannabis users, and healthy controls.

Boris B Quednow1, Kai-Uwe Kühn, Klaus Hoenig, Wolfgang Maier, Michael Wagner.   

Abstract

Chronic administration of 3,4-methylenedioxymethamphetamine (MDMA) is associated with long-term depletion of serotonin (5-HT) and loss of 5-HT axons in the brains of rodents and nonhuman primates. Despite the broad database concerning the selective serotonergic neurotoxicity of recreational MDMA consumption by humans, controversy still exists with respect to the question of whether the well-known functional consequences of these neurotoxic effects, such as memory impairment, were caused by chronic 5-HT deficiency. Habituation and prepulse inhibition (PPI) of the acoustic startle response (ASR) can be used as a marker of central serotonergic functioning in rodents and humans. Thus, we investigated the functional status of the central serotonergic system in chronic but abstinent MDMA users by measuring PPI and habituation of ASR. PPI and habituation of ASR were measured in three groups. The first group (MDMA group) included 20 male drug-free chronic users of MDMA; the second group (cannabis group) consisted of 20 male drug-free chronic users of cannabis; and the third group (healthy controls) comprised 20 male participants with no history of illicit drug use. Analysis revealed significantly increased PPI of MDMA users compared to those of cannabis users and healthy controls. Cannabis users and healthy controls showed comparable patterns of PPI. There were no differences in habituation among the three groups. These results suggest that the functional consequences of chronic MDMA use may be explained by 5-HT receptor changes rather than by a chronic 5-HT deficiency condition. Use of cannabis does not lead to alterations of amplitude, habituation, or PPI of ASR.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14970829     DOI: 10.1038/sj.npp.1300396

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  37 in total

1.  Cognitive impairment in cocaine users is drug-induced but partially reversible: evidence from a longitudinal study.

Authors:  Matthias Vonmoos; Lea M Hulka; Katrin H Preller; Franziska Minder; Markus R Baumgartner; Boris B Quednow
Journal:  Neuropsychopharmacology       Date:  2014-03-21       Impact factor: 7.853

2.  Alterations to pre-pulse inhibition (PPI) in chronic cannabis users are secondary to sustained attention deficits.

Authors:  Kirsty Elizabeth Scholes; Mathew Thomas Martin-Iverson
Journal:  Psychopharmacology (Berl)       Date:  2009-10-09       Impact factor: 4.530

3.  Cognitive and socio-cognitive functioning of chronic non-medical prescription opioid users.

Authors:  Sara L Kroll; Emilija Nikolic; Franziska Bieri; Michael Soyka; Markus R Baumgartner; Boris B Quednow
Journal:  Psychopharmacology (Berl)       Date:  2018-10-11       Impact factor: 4.530

4.  Corticosteroid dependent and independent effects of a cannabinoid agonist on core temperature, motor activity, and prepulse inhibition of the acoustic startle reflex in Wistar rats.

Authors:  Avdesh Avdesh; Vincent Cornelisse; Mathew Thomas Martin-Iverson
Journal:  Psychopharmacology (Berl)       Date:  2011-09-27       Impact factor: 4.530

5.  Sensorimotor gating deficits in schizophrenia: Advancing our understanding of the phenotype, its neural circuitry and genetic substrates.

Authors:  Neal R Swerdlow; Gregory A Light
Journal:  Schizophr Res       Date:  2018-03-07       Impact factor: 4.939

Review 6.  Sensorimotor gating deficits in "two-hit" models of schizophrenia risk factors.

Authors:  Asma Khan; Susan B Powell
Journal:  Schizophr Res       Date:  2017-10-22       Impact factor: 4.939

Review 7.  Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?

Authors:  Nadia Solowij; Patricia T Michie
Journal:  J Psychiatry Neurosci       Date:  2007-01       Impact factor: 6.186

8.  Smoking but not cocaine use is associated with lower cerebral metabotropic glutamate receptor 5 density in humans.

Authors:  L M Hulka; V Treyer; M Scheidegger; K H Preller; M Vonmoos; M R Baumgartner; A Johayem; S M Ametamey; A Buck; E Seifritz; B B Quednow
Journal:  Mol Psychiatry       Date:  2013-04-30       Impact factor: 15.992

9.  Gamma-Hydroxybutyrate Increases Resting-State Limbic Perfusion and Body and Emotion Awareness in Humans.

Authors:  Oliver G Bosch; Fabrizio Esposito; Michael M Havranek; Dario Dornbierer; Robin von Rotz; Philipp Staempfli; Boris B Quednow; Erich Seifritz
Journal:  Neuropsychopharmacology       Date:  2017-05-31       Impact factor: 7.853

10.  Startle reactivity in children at risk for migraine.

Authors:  Roman Duncko; Lihong Cui; Jeffrey Hille; Christian Grillon; Kathleen R Merikangas
Journal:  Clin Neurophysiol       Date:  2008-10-31       Impact factor: 3.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.